ATBC

(redirected from Alpha-Tocopherol, Beta-Carotene)
AcronymDefinition
ATBCAlpha-Tocopherol, Beta-Carotene (cancer prevention study)
ATBCAssociation for Tropical Biology and Conservation (Washington, DC)
ATBCAustralia Thailand Business Council (est. 1980)
ATBCAboriginal Tourism of British Columbia
ATBCApostolic Theological Bible College (est. 1978; Kaufman, TX)
ATBCArchitectural & Transportation Barriers Compliance Board
References in periodicals archive ?
Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
The current investigation included 1,000 participants in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study who were diagnosed with prostate cancer following enrollment.
Effects of alpha-tocopherol and beta-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study.
[2] Nonstandard abbreviations: 25(OH)D, 25-hydroxyvitamin D; ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention; CARET, Beta-Carotene and Retinol Efficacy Trial; VITAL, Vitamin D and Omega-3 Trial.
Why did antioxidants not protect against lung cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study?
Effects of alpha-tocopherol, beta-carotene and ascorbic acid on oxidative, hormonal and enzymatic exercise stress markers in habitual training activity of professional basketball players.
Although the Nurses Health Study, (2) a large cohort trial involving nearly 88,000 women, and other observational studies (LOE: 2) suggested a cardiovascular benefit from vitamin E, the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention study, (3) a well-designed RCT (LOE: 1) proved the opposite.
Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
Findings reported in 1994 from the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study in Finland were unexpected and troubling.
Stolzenberg-Solomon, PhD, and colleagues evaluated data from 29,092 men who participated in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a placebo-controlled trial that sought to determine the effect of vitamin E and beta-carotene supplementation on the prevention of cancers in smokers.
Although the Nurses Health Study, (2) a large cohort trial involving nearly 88,000 women, and other observational studies (SORT LOE: 2) suggested a cardiovascular benefit from vitamin E; the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention study, (3) a well-designed RCT (LOE: 1), proved the opposite.